Home

Ira Scott Greenspan

CIK 1449211 · Executive Committee Chairman · last filed 2021-11-26

Ira Scott Greenspan is an Executive Committee Chairman who has filed 16 SEC Form 4 insider transactions across 4 companies since 2016. The most recent filing, for SCPS, was dated Nov 26, 2021. Across all open-market trades the lifetime net is −$413.1K, making them a net seller over the disclosed history. 11 SEC filings were submitted jointly with PAVmed Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

4

Total Filings

16

Lifetime Open-Market Net

-$413.1K

Filer Profile

Reported Address
888 SEVENTH AVENUE
9TH FLOOR
NEW YORK, NY 10106
Related Filers
PAVmed Inc. — 11 joint filings, latest 2018-07-06
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Scopus BioPharma Inc. (SCPS) Delisted Executive Committee Chairman 97,090 $0.17 $16.3K $122.2K 11 2021-11-26
PAVmed Inc. (PAVMZ) Delisted 10%+ Owner 421,691 $0.00 $380 -$535.3K 2 2018-06-11
PAVmed Inc. (PAVMW) Delisted Director 48,465 $0.03 $1.4K $0 2 2017-12-06
PAVmed Inc. (PAVM.U) Delisted Director 152,873 — — $0 1 2016-05-02

Recent Filings

16 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2021-11-26 Scopus BioPharma Inc. (SCPS) Delisted Other (J) — $0 EDGAR
2021-08-30 Scopus BioPharma Inc. (SCPS) Delisted Buy (P) +900 $4.5K EDGAR
2021-08-25 Scopus BioPharma Inc. (SCPS) Delisted Buy (P) +550 $2.4K EDGAR
2021-08-23 Scopus BioPharma Inc. (SCPS) Delisted Buy (P) +2,400 $9.8K EDGAR
2021-08-19 Scopus BioPharma Inc. (SCPS) Delisted Buy (P) +2,000 $8.4K EDGAR
2021-08-03 Scopus BioPharma Inc. (SCPS) Delisted Other (J) — $0 EDGAR
2021-07-27 Scopus BioPharma Inc. (SCPS) Delisted Buy (P) +2,700 $12.8K EDGAR
2021-02-26 Scopus BioPharma Inc. (SCPS) Delisted Buy (P) +1,215 $11.1K EDGAR
2021-02-24 Scopus BioPharma Inc. (SCPS) Delisted Buy (P) +1,500 $14.5K EDGAR
2021-02-23 Scopus BioPharma Inc. (SCPS) Delisted Buy (P) +450 $4.5K EDGAR
Showing 1–10 of 16
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.